Literature DB >> 8974005

Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency.

G R Foster1, O Rodrigues, F Ghouze, E Schulte-Frohlinde, D Testa, M J Liao, G R Stark, L Leadbeater, H C Thomas.   

Abstract

Interferon-alpha (IFN-alpha) subtypes were separated by HPLC from the IFN mixtures produced by virus-stimulated human lymphoblastoid cells and leukocytes. Together with preparations of lymphoblastoid IFN and recombinant IFN-beta, these were tested in three human tumor cell lines derived from liver, lung, and neuroblasts. Their relative antiviral activities differed markedly: subtype IFN-alpha 8 was the most potent and IFN-alpha 1 the least. The results were broadly similar in all three cells, with some minor differences. when the same preparations were tested for inhibition of thymidine incorporation, the relative activities were quite different: subtypes IFN-alpha 10, IFN-alpha 17, IFN-alpha 21, and IFN-alpha 5 were now the most active, and IFN-alpha 2 was the least active. IFN-alpha 1 and IFN-alpha 8 had comparable intermediate activity. Thus, the differences in activity were not caused by degradation of some subtypes during their separation. IFN-alpha 8 not only had the greatest antiviral activity but also, like IFN-beta, induced an antiviral state in U1 mutant cell lines, which lack the tyrosine kinase, Tyk2, required for signal transduction by other IFN-alpha subtypes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8974005     DOI: 10.1089/jir.1996.16.1027

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  23 in total

Review 1.  Type I interferons: crucial participants in disease amplification in autoimmunity.

Authors:  John C Hall; Antony Rosen
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

2.  Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes.

Authors:  T A Nyman; H Tölö; J Parkkinen; N Kalkkinen
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

3.  Characterization of bovine interferon α1: expression in yeast Pichia pastoris, biological activities, and physicochemical characteristics.

Authors:  Jianwei Shao; Chong Cao; Jun Bao; Hongtao Liu; Tongquan Peng; Mingchun Gao; Junwei Wang
Journal:  J Interferon Cytokine Res       Date:  2014-10-24       Impact factor: 2.607

4.  High-throughput quantitative real-time polymerase chain reaction array for absolute and relative quantification of rhesus macaque types I, II, and III interferon and their subtypes.

Authors:  Lynnsie M Schramm; Kevin D Kirschman; Melissa Heuer; Aaron A Chen; Daniela Verthelyi; Montserrat Puig; Ronald L Rabin
Journal:  J Interferon Cytokine Res       Date:  2012-07-20       Impact factor: 2.607

5.  Maturation-dependent responses of human neuronal cells to western equine encephalitis virus infection and type I interferons.

Authors:  Kathryn M Castorena; Daniel C Peltier; Weiping Peng; David J Miller
Journal:  Virology       Date:  2007-11-26       Impact factor: 3.616

6.  IFN-alpha expression and antiviral effects are subtype and cell type specific in the cardiac response to viral infection.

Authors:  Lianna Li; Barbara Sherry
Journal:  Virology       Date:  2009-11-06       Impact factor: 3.616

7.  Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7.

Authors:  Pierre Génin; Rongtuan Lin; John Hiscott; Ahmet Civas
Journal:  Mol Cell Biol       Date:  2009-04-06       Impact factor: 4.272

Review 8.  The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

Authors:  Consuelo M López de Padilla; Timothy B Niewold
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

9.  Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.

Authors:  Carolina Scagnolari; Milvia Casato; Francesca Bellomi; Francesca De Pisa; Ombretta Turriziani; Rossella Coviello; Maria Rosaria Pirro; Ferdinando Dianzani; Guido Antonelli
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

10.  Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality.

Authors:  Prakasha Kempaiah; Samuel B Anyona; Evans Raballah; Gregory C Davenport; Tom Were; James B Hittner; John M Ong'echa; Douglas J Perkins
Journal:  Hum Genet       Date:  2012-05-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.